Are clinical trials into emerging drugs for the treatment of alpha-1 antitrypsin deficiency providing promising results?

IF 2.7 3区医学 Q2 PHARMACOLOGY & PHARMACY

Expert Opinion on Emerging Drugs Pub Date : 2023-12-01 Epub Date: 2023-12-26 DOI:10.1080/14728214.2023.2296088

Joshua De Soyza, Anita Pye, Alice M Turner

引用次数: 0

查看原文本刊更多论文

治疗α-1 抗胰蛋白酶缺乏症的新药临床试验是否取得了可喜的成果？

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Expert Opinion on Emerging Drugs 医学-药学

CiteScore

5.90

自引率

0.00%

发文量

审稿时长

>12 weeks

期刊介绍： Expert Opinion on Emerging Drugs (ISSN 1472-8214 [print], 1744-7623 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing structured reviews on Phase II and Phase III drugs/drug classes emerging onto the market across all therapy areas, providing expert opinion on their potential impact on the current management of specific diseases.